CliffBio
small molecule

EVEKEO ODT

AMPHETAMINE SULFATE

Loss of exclusivityMarch 2037latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameEVEKEO ODT
Active ingredientAMPHETAMINE SULFATE
Strength10MG
Dosage formTABLET, ORALLY DISINTEGRATING
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 2019
Marketing statusDISCN

Listed patents

PatentExpiresType
11896562March 2037use U-3299
11160772March 2037product
10441554March 2037product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

EVEKEO ODT patent cliff — loss of exclusivity March 2037 | CliffBio